Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b
about
Function, regulation and pathological roles of the Gab/DOS docking proteinsHCV NS5A protein containing potential ligands for both Src homology 2 and 3 domains enhances autophosphorylation of Src family kinase Fyn in B cells.Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFATRoles of E3 ubiquitin ligases in cell adhesion and migration.E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancersc-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.Cbl-b Deficiency in Mice Results in Exacerbation of Acute and Chronic Stages of Allergic Asthma.The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.Regulation of the mast cell response to the type 1 Fc epsilon receptor.E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunitySrc-like adaptor protein (SLAP) is upregulated in antigen-stimulated mast cells and acts as a negative regulator.Association of C-Type Lectin Mincle with FcεRIβγ Subunits Leads to Functional Activation of RBL-2H3 Cells through Syk.Cbl family proteins: balancing FcεRI-mediated mast cell and basophil activation.Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.Inhibition of hepatitis C virus replication through adenosine monophosphate-activated protein kinase-dependent and -independent pathways.Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals.Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.Inhibition of CBLB protects from lethal Candida albicans sepsis.Activation/Inhibition of mast cells by supra-optimal antigen concentrationsG-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.Detecting anti-FcepsilonRI autoantibodies in patients with asthma by flow cytometry.Interaction of DJ-1 with Lyn is essential for IgE-mediated stimulation of human mast cells.Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation.E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway.Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus.C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
P2860
Q21245511-F8E6200C-7624-4C69-9361-AD25F3B20ED4Q30009991-AE096C89-9555-46A2-92B2-8601A6638DAFQ30157087-96AC55A2-2542-45E8-B8A0-2DD69058099BQ33781079-4F979986-3BE3-4CDA-B4BC-6D29A3A46793Q33953086-0341A9CA-1036-4D77-8DD0-527EFC08F207Q35740062-AD684ED2-A88D-4710-89AD-C5745182E66FQ36280423-F3481B7C-B44B-46B3-BFF4-9B463754C7B2Q36300645-059DA9DC-329B-4A85-B3EB-DC7D4B353818Q36356112-61CD1260-F835-443D-9780-70D1AE34FB5BQ36819928-7F6AB792-94D6-49D7-82B8-12ED9B299552Q37179037-07F6C400-6C77-4D9E-983C-FE50A00B07FBQ37199195-C72A2E19-BC98-4C44-9FAF-8E508F7272D2Q37743169-DB37C116-E95F-40D2-9B3C-70FB8B5E26C8Q37859217-983A981A-108C-4F0B-96C6-FCFAAF673B39Q38393275-40C42DF9-DFDF-4794-B8F9-73200FC67A21Q39070383-E4C303F9-C82C-4D0E-A4B3-27BF8B80AD2CQ39374254-7A2009B6-C2CD-4F3A-909D-0C10DFDB128BQ39479021-0D5F69EF-2FF7-44BA-95A1-64B4E6A64DD0Q39840784-9C2404CA-19F5-4C5F-9CE7-A282C6A7A3FAQ39882955-9E923612-4CBF-4B08-80EF-4863970E1953Q40610011-D9E4D960-1F7F-4287-B298-A148A0C12C39Q41094713-DDE4677E-5D98-4940-9FAA-3C7CE344305FQ42051165-E5542EF6-AF2C-4DF4-9362-27E6995F390BQ45836560-41F93DCB-BD3B-479E-BD5A-1CA07742FD9DQ46285696-17F7F585-E6A1-4B3C-9649-0E3D85BA86C0Q46398400-9A527DB1-95E5-44EC-98A9-232E6EA790D7Q50439358-DD147954-9032-4404-B057-889B7F6656C2Q53667349-6D2CEFE0-EDAA-45B5-93F6-362927D681F7Q55092508-32880913-BFC2-4E11-9386-35F41D40511E
P2860
Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b
description
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im März 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/03/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/03/01)
@nl
наукова стаття, опублікована в березні 2004
@uk
مقالة علمية (نشرت في مارس 2004)
@ar
name
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@ast
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@en
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@nl
type
label
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@ast
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@en
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@nl
prefLabel
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@ast
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@en
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@nl
P2093
P3181
P1433
P1476
Negative regulation of Fcepsil ...... ubiquitin-protein ligase Cbl-b
@en
P2093
Hirohei Yamamura
Koichiro Maeno
S. M. Shahjahan Miah
Shinkou Kyo
Xiujuan Qu
P304
P3181
P356
10.1182/BLOOD-2003-07-2260
P407
P50
P577
2004-03-01T00:00:00Z